Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Side Effects Part I (June/July) | 2019

View Archived Issues

CME Post-Test - Side Effects Part I, TCPR, June/July 2019

July 3, 2019

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Mood Stabilizers and Stroke Risk in Bipolar Disorder

July 3, 2019

Thomas Jordan, MD.

Why does stroke matter in bipolar disorder? Because it’s the leading cause of death for these patients. Some mood stabilizers raise the stroke risk, while others do not. Read More

Lithium in Geriatric Depression

July 3, 2019

Jason Mallo, DO

Lithium is underutilized in geriatric depression, but this study suggests it may have unique benefits there. Read More

New Augmentation Strategies in OCD

July 3, 2019

Michael Posternak, MD.

Two medications show promise in OCD, and their mechanisms are novel: one glutamatergic, one dopaminergic. Read More

Esketamine Gets FDA Approval

July 3, 2019

On March 5, 2019, the FDA approved esketamine (Spravato) nasal spray as add-on therapy to traditional antidepressant medications for treatment-resistant depression (TRD). In this article, I will describe the events that led to esketamine’s development, review the data submitted to the FDA, and discuss what the future might hold for esketamine. Read More

Risk Evaluation and Mitigation Strategy (REMS) Programs

July 3, 2019

Certain psychiatric treatments require both the healthcare provider and patient to enroll in a Risk Evaluation and Mitigation Strategy (REMS) program before they are administered. Here are links to enroll. Read More

Medication Side Effects: Nausea, Sweating, and Dry Mouth

July 3, 2019

Rajnish Mago, MD

Does ginger ale treat nausea? Not really, but Dr. Mago has some better ideas, and this interview is packed with new and practical ways to manage common side effects of psychiatric medications. Read More

Are Auditory Hallucinations Ever Normal?

July 3, 2019

Joseph M. Pierre, MD.

When a patient presents with auditory hallucinations (AH), are you likely to diagnose a psychotic disorder? If no other symptoms are present, would you recommend an antipsychotic? If you answered yes to either question, there’s some new research that may change your mind. Read More

Brexanolone (Zulresso) for Postpartum Depression

July 3, 2019

Talia Puzantian, Chris Aiken, MD, and Chris Aiken

Every week of depression takes a toll on infant development, so this rapid-acting treatment fills a unique need. Here we review the clinical data and the pragmatics of getting patients connected with the therapy. Read More

A New Dopamine and Norepinephrine Reuptake Inhibitor for Excessive Sleepiness

July 3, 2019

Talia Puzantian, Chris Aiken, MD, and Chris Aiken

Solriamfetol (Sunosi) was just approved for excessive daytime sleepiness in narcolepsy and sleep apnea, but it may have important psychiatric effects as well. Read More